Home » Topics » Regulatory

Regulatory
RSS

Abbott in-licenses lipid-lowering drug from Fournier

Jan. 14, 1998

New use approved for Lescol

Jan. 14, 1998

Roberts seeks to broaden market for Agrylin

Jan. 13, 1998

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

Jan. 9, 1998

FDA clears Optison

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Astra to launch new tablet formulation of Losec in Sweden

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

NDA filed for extended-release Ditropan formulation

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...